English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 854163      Online Users : 1519
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    期刊論文 [327/330]
    圖書 [1/1]
    會議論文/會議摘要 [115/179]

    Community Statistics


    近3年內發表的文件:74(14.51%)
    含全文筆數:443(86.86%)

    文件下載次數統計
    下載大於0次:443(100.00%)
    下載大於100次:424(95.71%)
    檔案下載總次數:176904(3.30%)

    最後更新時間: 2024-11-28 13:36

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 201-210 of 510. (51 Page(s) Totally)
    << < 16 17 18 19 20 21 22 23 24 25 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2018-02 Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials Journal of Clinical Oncology. 2018 Feb;36(4, Suppl.):Abstract number 90.
    2018-02 Dose modifications of liposomal irinotecan (nal-IRI)+5-fluorouracil/leucovorin (5-FU/LV) in NAPOLI-1: Impact on efficacy Journal of Clinical Oncology. 2018 Feb;36(4, Suppl.):388.
    2018-02 Subgroup analysis by baseline pain intensity (BPI) and analgesic use (BAU) in NAPOLI-1: A phase III study of liposomal irinotecan (nal IRI)+/- 5-fluorouracil/leucovorin (5-FU/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) p Journal of Clinical Oncology. 2018 Feb;36(4, Suppl.):379.
    2018-02 Subgroup analysis by baseline (BL) weight-associated parameters: A phase III study of liposomal irinotecan (nal-IRI)+/--5fluorouracil/leucovorin (5-FU/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with g Journal of Clinical Oncology. 2018 Feb;36(4, Suppl.):410.
    2018-01 Orchestration of H3K27 methylation: Mechanisms and therapeutic implication Cellular and Molecular Life Sciences. 2018 Jan;75(2):209-223.
    2018-01 Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer; A JSMO - ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS Annals of Oncology. 2018 Jan;29(1):44-70.
    2018-01 Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma Journal of Clinical Oncology. 2018 Jan;36(3):276-282.
    2018-01 Environmental tobacco smoke and risk of pancreatic cancer among never smokers Cancer Science. 2018 Jan;109(Suppl. 1):769.
    2018-01 Role of academic institute in cancer therapy development in National Institute of Cancer Research, NHRI in Taiwan Cancer Science. 2018 Jan;109(Suppl. 1):43.
    2018-01 The role of aberrant mitochondrial phosphoenolpyruvate carboxykinase expression in pancreatic neuroendocrine tumors Cancer Science. 2018 Jan;109(Suppl. 1):466.

    Showing items 201-210 of 510. (51 Page(s) Totally)
    << < 16 17 18 19 20 21 22 23 24 25 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback